Advocating for a better quality of life for people living with Metastatic Breast Cancer through Patient-Centered Dosing.
Metastatic Breast Cancer patients will continue treatment for the remainder of our lives, and we cannot be cured.
We therefore call into question the practice of repeatedly treating us with the highest possible dosage that causes the most challenging side effects — especially since we will repeatedly endure the most toxic dose at the beginning of each new regimen.
Thank you to the 1,221 people who took #TheRightDoseSurvey
Our advocacy team is building a framework to help physicians and their patients carefully select the optimal approved dosage based upon each patient’s unique needs.
We’ve collected data from people living with Metastatic Breast Cancer (MBC) to support the Patient-Centered Dosing Initiative.